The Team
Meet Duluth Medical Technologies:
A Team of seasoned executives and technical professionals
Fred Seddiqui
CEO
Fred Seddiqui has 25 yrs Exp in emerging companies. Fred sold PS Inc., an internet based medical company to Packet Stream Inc. in 2002, he also sold Sharp Surgical to Cook Medical in 2012. Other of his startup companies such as AFx Inc. was acquired by Boston Scientific in 2004 and Vivant Medical Technologies was acquired by Covidien in 2005. Fred has also served as CEO and Chairman of the Board of Axis Surgical Technologies Inc. (now called Trice Medical) and Avantis Medical Systems.
Dr. Ruchi Dana
COO
Dr Ruchi Dana has 10 yrs Exp in emerging companies, medical devices. Ruchi is a trained Medical Practitioner, transitioned to a successful Entrepreneur and Business Leader. Ruchi has also been recognized as Forbes ME Power Businesswoman 2020She is recognized by Forbes Magazine as NexGen Leader for 3 consecutive years 2017, 2018 and 2019, Women to Watch by Campden Wealth 2018. Ruchi is a Stanford Biodesign Fellow and Stanford MBA’13
Mike Fourkas
AI Lead
Mike has 25 yrs Exp as senior management and engineering roles. Mike has rich experience in designing, developing and manufacturing Medical Devices and getting regulatory approvals. He received multiple 510k clearances for many of his previous companies. Mike holds a BSME form California Poly San Luis Obispo and an MSME from Stanford University
Rachel Spykerman
AI Lead
Rachel has worked in the analog and semiconductor industry for 6 years, and in the last 2 years, has focused her role within the robotics industry, developing computer vision and AI related applications. Rachel holds a BASc + PEY in Electrical Engineering from the University of Toronto
Meet the members of Duluth‘s Board of Advisors with deep experience in
the field of Medicine, Finance, BioPharma, MedTech and AI Technologies
Derek Minno
Derek has over 25 years experience with growth companies as an investor/financial manager and has worked with numerous management teams to create investment value.
Trigg McClellan, MD
Dr. McClellan is a Clinical Professor of Orthopedic Surgery at University of California, San Francisco and the co-director of the orthopedic spine service at San Francisco General Hospital.
Daniel Solomon MD
Dr. Solomon is an otheprdic surgeon affiliated with multiple hospitals in the San Francisco including Novato Community Hospital, Marin Orthopedics, and Marin General Hospital. He has contributed to over 70 publications.
Jefferey Barry MD
Dr. Barry is an orthopedic surgeon affiliated with multiple hospitals in the San Francisco area including San Francisco VA Medical Center and UCSF Medical Center. He has a B.S.E (magna cum laude) in Biomedical Engineering from Duke University. And received his medical degree from UCSF. He specializes in knee and hip reconstruction.
Bharat Tewarie, MD, MBA
Dr Bharat Tewarie is an C-suite leader with an extensive background in BioPharma Management and Medical Devices in USA and Europe. During his extensive career he has held positions with increasing medical and commercial responsibilities at Boehringer Ingelheim, Roche, Serono International, EMD Serono, Merck Serono and UCB.
He is a thought leader and key note speaker on company and product turnarounds, product and medical device launches, insight at scale, access & pricing, patient experience, digital transformation and specifically AI to address biopharma business challenges
